Monovisc 88mg Injection is a sterile, preservative-free solution of sodium hyaluronate, a naturally occurring substance found in the human body. It is indicated for the treatment of osteoarthritis-related pain and inflammation of the knee. The product is administered by intra-articular injection and provides a sustained release of hyaluronate, which helps to maintain the natural lubrication and shock-absorbing properties of the joint. Sodium hyaluronate has anti-inflammatory and anti-edema properties, which contribute to its analgesic and symptomatic relief effects. Monovisc 88mg Injection is contraindicated in patients with hypersensitivity to sodium hyaluronate or any component of the product. The most common adverse reactions reported are injection site reactions, including pain, swelling, and stiffness, which are usually mild and transient. The recommended dose is a single injection of 2 mL (88mg) into the affected knee. Monovisc 88mg Injection is a valuable therapeutic option for patients seeking relief from the symptoms of osteoarthritis-related knee pain and inflammation.